PsychiatryNews.net

Psychiatry Xagena

Xagena Mappa
Medical Meeting
Neurobase.it
Ematobase.it

The FDA ( U.S. Food and Drug Administration ) has approved a supplemental new drug application ( sNDA ) for Trintellix ( Vortioxetine ), a medication used for adults with major depressive disorder ( M ...


A study has examined prenatal Paracetamol ( Acetaminophen [ N-acetyl-p-aminophenol ]; APAP ) exposure in relation to language development in offspring at 30 months of age. A population-based pregna ...


Varenicline ( Chantix, Champix ) aids in smoking cessation but has also been associated with serious adverse events. The aim of a study was to determine the risks of cardiovascular and neuropsychia ...


Results for a phase 3 study of Cariprazine ( Vraylar ) for the treatment of adults with major depressive episodes associated with bipolar I disorder ( bipolar I depression ) were announced. This is ...


Poppers are volatile alkyl nitrite compounds that are inhaled to enhance sexual experience and for their psychoactive effects. A less well-known side effect is foveal maculopathy, which has emerged ...


The aim of the study was to estimate the risk of fatal and non-fatal myocardial infarction and stroke in patients with bipolar I disorder compared to people without bipolar I disorder. Utilizing a ...


Sexual dysfunction is common with serotonergic antidepressants, including selective serotonin reuptake inhibitors ( SSRIs ) and serotonin-norepinephrine reuptake inhibitors ( SNRIs ), and does not res ...


A study from the University of Eastern Finland in collaboration with Deakin University, Australia, has shown that recurrent major depressive disorder ( MDD ) in men is associated with lower bone densi ...


The reported risk of depression in patients with hypomagnesaemia is controversial. The objective of a meta-analysis was to assess the association between depression and hypomagnesaemia. Six obse ...


The objective of a study was to examine the risk for persistent pulmonary hypertension of the newborn associated with antenatal exposure to antidepressants. Of the 3077 abstracts reviewed, 738 pape ...


The results from the CONNECT study showing that Vortioxetine ( Brintellix ) 10 to 20 mg/day in adults with major depressive disorder ( MDD ) met the primary study endpoint of demonstrating superiority ...


Placebo-controlled trials indicate that Cytisine, a partial agonist that binds the nicotinic acetylcholine receptor and is used for smoking cessation, almost doubles the chances of quitting at 6 month ...


Antipsychotics and mood stabilisers are prescribed widely to patients with psychiatric disorders worldwide. Despite clear evidence for their efficacy in relapse prevention and symptom relief, their ef ...


Few pharmacotherapies have demonstrated sufficient efficacy in the treatment of posttraumatic stress disorder ( PTSD ), a chronic and disabling condition. A study has evaluated the efficacy and saf ...


Depressive symptoms are common in schizophrenia and can worsen outcomes and increase suicide risk. Lurasidone ( latuda ) is an atypical antipsychotic agent indicated for the treatment of schizophrenia ...